Hard to keep up all the CV meetings?
JCF has got ya for HF!
Succinct meeting summaries
#AHA2024 to follow soon
💠HFSA: https://t.co/PUq3UWWuKL
💠ESC: https://t.co/6QuIq0fUWi
💠ACC: https://t.co/JTRwWeplGI
🚨 Featured Science Alert! 🚨
Join us for “Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations.”
📅 Date: Mon, Nov 18
⏰ Time: 9:45 AM - 11:00 AM (CST)
📍 Room: S103BC
Don’t miss cutting-edge insights! 🔬❤️
#Cardiomyopathy#AHA24
🚨 Featured Science Alert! 🚨
Join us for “Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations.”
📅 Date: Mon, Nov 18
⏰ Time: 9:45 AM - 11:00 AM (CST)
📍 Room: S103BC
Don’t miss cutting-edge insights! 🔬❤️
#Cardiomyopathy#AHA24
Don't miss "Heart-to-Heart: Insights from a Patient and Heart Team" at #AHA24!
Explore the crossroads of adult congenital heart disease, AHF, and structural heart disease.
📆Sat, Nov 16
⏰3:15 PM - 4:30 PM (Central)
📍Heart Theater I
@CardioNerds@SarahChuzi@VorovichHeartMD
⭐️Our piece (w/ Sarah Godfrey & Katie Manning) on How to be a Palliative Cardiologist is out in @JCardFail ⭐️
Here, we describe unique training pathways & career phenotypes for HF 🧑🏾⚕️ who want to cultivate a niche in pall care.
📣Trainees- it’s possible & extremely rewarding!
Had fun giving talks on #HFpEF at the @HFSA board review course today. Made some "HFpEF connections" puzzles for the audience, in the style of @nytimes connections puzzles. See if you can figure it out! Match groups of 4 clues that are connected. https://t.co/nIK1Cxcd3e
📢 📢🚨 A Must Read!
🫀🔬 This @JCardFail Review on the Management of OHCM thoroughly details the current treatment landscape, evidence limitations, and clinical application challenges
Plus it is packed with clinical trial insights #cardiacmyosinmodulators#OHCM ☺️🤓
Even with protocols in place, there is room for bias in the heart transplant eval.
We looked at all pts evaluated for HT at our 🏥 over 8 yrs. ⬇️
1️⃣ Substance use cited as ineligibility factor in 151/1148 evaluated pts. Only 16 (‼️) of those pts went on to get HT!
🚨Reviewer Mentoring Program FINAL CALL 🚨
🌟Expand your knowledge in peer review publishing and gain invaluable experience in reviewing academic papers. The deadline to apply for the program is 5/17.
🔗 Apply and learn more: https://t.co/oggOzYRJYQ https://t.co/IjZnZoygH5
🔥Out now in #JCF! This brief report shows that in the ongoing FINEARTS-HF trial, incorporating UACR reclassified kidney risk in 1/3 trial pts and US adults with HF, emphasizing the importance of albuminuria as part of comprehensive risk assessment.
🔗https://t.co/6D5jvb2sQe
Feel like CV meetings can be overwhelming?!
The JCF team has “got ya” for HF insights.
New offering - @JCardFail summarizes key new insights from CV meetings!!
Check out ACC & ISHLT here:
https://t.co/JTRwWeplGI
https://t.co/e8Lh332oK7